Global Radiopharmaceuticals Market Insight

Publisher Name :
Date:6-Feb-2014
No. of pages: 450

Radioisotopes are radioactive isotopes having an unstable balance of atomic nucleus.  Radioisotopes are produced either by using nuclear research reactor or by using cyclotron. These isotopes emit energy in the form of alpha, beta or gamma when changed to a stable nature. The gamma rays, thus emitted are used in Nuclear medicine, specifically in medical diagnostics. In this field, the radiation is used to provide diagnostic information about a human body’s functioning.  Radiotherapy is also used to treat some life-threatening diseases like cancer. Also, it has been observed that the increasing use of radioisotopes is one of the major reasons for a fall in deaths caused by cancer across the globe. It is because of this feature that the demand for radioisotopes or otherwise called radiopharmaceuticals is increasing significantly.

A major part of the radiopharmaceuticals market is dominated by diagnostic radiopharmaceuticals, where, SPECT and PET isotopes are most common. The new innovations in nuclear medicine to target coronary heart disease, Alzheimer’s disease, breast cancer, and bone metastasis would be the major drivers of the diagnostic radiopharmaceuticals market in the future. The other segment of the market is the therapeutic segment, which accounts for the remaining 10%. This segment is mainly dominated by isotopes like I-131, Sm-153, Re-186, Y-90, and Lu-177. It is expected that over the next 5-6 years horizon, this market would witness a steep increase owing to the introduction of many new products for treating lymphoma, colon cancer, lung cancer, prostate cancer, bone cancer and other persistent cancers.

The increasing popularity and use of SPECT and PET scans, new and efficient technological equipment, increased awareness about radiopharmaceuticals among physicians and most importantly, the easy availability of radiopharmaceutical from cyclotrons are some of the major factors driving the global radiopharmaceutical market.

Inspite of the market for radiopharmaceuticals growing rapidly, there are many challenges, like high cost of devices using radioisotopes, short half-life, lack of good manufacturing practices, and stringent regulatory approvals. Additionally, there are also some obstacles with regards to the manufacturing of radioisotopes, which need to be addressed to tap the opportunities.

The global market for radiopharmaceuticals was estimated to be valued at approximately USD 5.3 billion in 2013. Owing to factors like the increasing adoption rates of PET and SPECT scanners, alpha radioimmunotherapy based targeted cancer treatment, and ready availability of radiopharmaceutical from cyclotrons, coupled with significant developments in research and technology, this market is expected to record a CAGR of close to 15% to reach approximately USD 10.6 billion by 2018.

“Global Radiopharmaceuticals Market Insight” Report Highlights

  • Global Radio Pharmaceuticals Market Overview by Region
  • Target Patient Base by Region
  • Radiopharmaceuticals Market Regulation for US, Europe & Canada
  • Radioisotopes Used in Radiopharmaceuticals
  • Radiopharmaceutical Clinical Pipeline Insight
  • Profile of 87 Radiopharmaceuticals Drugs in Clinical Phase

Global Radiopharmaceuticals Market Insight

Table of Contents

1. Global Radiopharmaceuticals Market Outlook
1.1 Market Overview
1.2 Diagnostic & Therapeutic Radiopharmaceuticals
1.3 Market Dynamics
1.4 Radioisotopes Used in Radiopharmaceuticals
1.5 Radiopharmaceuticals in Clinical Development Phase

2. Europe Guidelines for Radiopharmaceuticals
2.1 Physico-Chemical, Biological or Microbiological Tests of Medicinal Products
2.2 Toxicological & Pharmacological Tests
2.3 Clinical Documentation
2.4 Radiation Dosimetry
2.5 Labelling & Packaging

3. US Guidelines for Radiopharmaceuticals
3.1 Clinical Indication
3.2 General Considerations for Safety Assessments
3.3 Clinical Evaluation of Medical Imaging Agents

4. Canada Guidelines for Radiopharmaceuticals
4.1 Use of Positron Emitting Radiopharmaceuticals (PERs) in Basic Research
4.2 Use of Positron Emitting Radiopharmaceuticals in Basic Research involving Humans
4.3 Stability Testing of Existing Drug Substances and Products
4.4 Good Manufacturing Practices (GMP) for Positron Emitting Radiopharmaceuticals (PERs)

5. Radiopharmaceuticals Clinical Trial Insight by Indication, Country & Phase
5.1 Phase Unknown
5.2 Research
5.3 Preclinical
5.4 Clinical
5.5 Phase 0
5.6 Phase I
5.7 Phase I/II
5.8 Phase II
5.9 Phase III
5.10 Preregistration
5.11 Registered

6. Marketed Radiopharmaceuticals by Indication & Country

7. Discontinued & Suspended Radiopharmaceuticals Drug Profiles by Indication, Country & Phase
7.1 Discontinued Clinical Trials for Radiopharmaceuticals
7.2 Suspended Clinical Trials for Radiopharmaceuticals
7.3 No Development Reported

8. Competitive Landscape
8.1 Avid Radiopharmaceuticals
8.2 Actinium Pharmaceuticals
8.3 AREVA Med
8.4 Bayer HealthCare Pharmaceuticals
8.5 Cardinal Health
8.6 Immunomedics
8.7 Lantheus Medical Imaging
8.8 Merck & Co
8.9 Navidea
8.10 Nordion
8.11 Lantheus Medical Imaging
8.12 GE Healthcare
8.13 Ion Beam Applications
8.14 PETNET Solutions (Siemens Healthcare Global)

List of Tables

Table 1-1: Calcium-47 Investigation Properties as Radiopharmaceuticals Drug
Table 1-2: Carbon-11 Investigation Properties as Radiopharmaceuticals Drug
Table 1-3: Carbon-14 Investigation Properties as Radiopharmaceuticals Drug
Table 1-4: Chromium-51 Investigation Properties as Radiopharmaceuticals Drug
Table 1-5: Cobalt-57 Investigation Properties as Radiopharmaceuticals Drug
Table 1-6: Cobalt-58 Investigation Properties as Radiopharmaceuticals Drug
Table 1-7: Erbium-169 Investigation Properties as Radiopharmaceuticals Drug
Table 1-8: Fluorine-18 Investigation Properties as Radiopharmaceuticals Drug
Table 1-9: Gallium-67 Investigation Properties as Radiopharmaceuticals Drug
Table 1-10: Gallium-68 Investigation Properties as Radiopharmaceuticals Drug
Table 1-11: Hydrogen-3 Investigation Properties as Radiopharmaceuticals Drug
Table 1-12: Indium-111 Investigation Properties as Radiopharmaceuticals Drug
Table 1-13: Iodine-123 Investigation Properties as Radiopharmaceuticals Drug
Table 1-14: Iodine-125 Investigation Properties as Radiopharmaceuticals Drug
Table 1-15: Iodine-131 Diagnostic Investigation Properties as Radiopharmaceuticals Drug
Table 1-15: Iodine-131 Therapeutic Investigation Properties as Radiopharmaceuticals Drug
Table 1-16: Iron-59 Investigation Properties as Radiopharmaceuticals Drug
Table 1-17: Krypton-81m Investigation Properties as Radiopharmaceuticals Drug
Table 1-18: Nitrogen-13 Investigation Properties as Radiopharmaceuticals Drug
Table 1-19: Oxygen-15 Investigation Properties as Radiopharmaceuticals Drug
Table 1-20: Phosphorus-32 Investigation Properties as Radiopharmaceuticals Drug
Table 1-21: Radium-223 Investigation Properties as Radiopharmaceuticals Drug
Table 1-22: Rubidium-82 Investigation Properties as Radiopharmaceuticals Drug
Table 1-23: Samarium-153 Investigation Properties as Radiopharmaceuticals Drug
Table 1-24: Selenium-75 Investigation Properties as Radiopharmaceuticals Drug
Table 1-25: Sodium-22 Investigation Properties as Radiopharmaceuticals Drug
Table 1-26: Sodium-24 Investigation Properties as Radiopharmaceuticals Drug
Table 1-27: Strontium-89 Investigation Properties as Radiopharmaceuticals Drug
Table 1-28: Technetium-99m Investigation Properties as Radiopharmaceuticals Drug
Table 1-29: Thallium-201 Investigation Properties as Radiopharmaceuticals Drug
Table 1-30: Xenon-133 Investigation Properties as Radiopharmaceuticals Drug
Table 1-31: Yttrium-90 Investigation Properties as Radiopharmaceuticals Drug

List of Figures

Figure 1-1: Global Radiopharmaceuticals Market (US$ Billion), 2013-2018
Figure 1-2: Global Radiopharmaceuticals Market by Region (%), 2013 & 2018
Figure 1-3: Global Radiopharmaceuticals Market by Region (US$ Billion), 2013 - 2018
Figure 1-4: Target Patient Base for Radiopharmaceuticals (Million), 2013-2018
Figure 1-5: Target Patient Base for Radiopharmaceuticals by Region (%), 2013 & 2018
Figure 1-6: Target Patient Base for Radiopharmaceuticals by Region (Million), 2013 - 2018
Figure 1-7: Radiopharmaceuticals Development by Clinical Phase (%), 2014
Figure 1-8: Radiopharmaceuticals Development by Clinical Phase (Number of Drugs), 2014
Figure 1-9: Suspended & Discontinued Radiopharmaceuticals in Clinical Phase (Number of Drugs), 2014
Figure 8-1: Lantheus Medical Imaging Product Pipeline

  • Challenges in the Tourism Industry in Thailand
    Thailand has always been a popular tourist destination and tourism provides a major boost to the country’s economy. Bangkok, Hua Hin, Krabi, Samui, Phuket and Cha Am are some of the most attractive tourist destinations in the country. In 2012, Thailand had a very high number of arrivals. Even the number of Thai citizens who [...]
  • Future of the US Consumer Electronics Market
    The market for consumer electronics has been growing steadily. Some of the factors that are contributing to the growth in the market are technological advancement, rise in disposable income and increasing demand for new products. During 2012, consumer electronics market in the US demonstrated positive expansion, although the growth rate slowed down considerably following the [...]
  • Overview of the Global Retail Market
    The global retail industry continued to grow despite the difficult economic conditions in the world. In the fiscal year of 2011, sales-weighted, currency-adjusted revenue rose by 5.1% to $4.271 trillion for the world’s top 250 retailers. According to GRDI (Global Retail Development Index), in 2013 Brazil occupied the top spot in retail development. Chile and [...]
  • Bright Future Predicted for the Tourism Industry in Singapore
    Travel and tourism industry in Singapore has been growing at a steady rate and is considered to be a major contributor to the economic growth of the country. In 2012, Singapore’s IVA (International Visitors Arrivals) reached a record high of 14.5 million, with a growth rate of 10.1% year-on-year. In recent years, inbound travel to [...]
  • Potential of Staffing Market in United States
    The staffing industry places individuals into contract, temporary and permanent positions in firms around the world. Major staffing markets include France, Spain, Italy and Japan as well as many emerging markets. Temporary staffing around the world has been growing, but in US temporary market has been flat since 2006. The majority of staffing revenue majorly [...]
  • Diagnostic X-ray Imaging Market worth $4.0 billion by 2020
  • GlobalData estimates that the global diagnostic X-ray imaging market, worth $2.4 billion in 2012, will reach almost $4.0 billion by 2020, increasing at a Compound Annual Growth Rate (CAGR) of 6.7% during the forecast period. Many players are active in …

  • Graft-Versus-Host Disease Market Forecast to 2023
  • Graft-versus-host disease (GVHD) is a common complication of allogeneic hematopoietic stem cell transplantation (HSCT) that occurs when the donated (graft) cells are rejected and attack the host’s cells as foreign. GVHD can progress from mild to severe forms as either …

  • Chronic Lymphocytic Leukemia (CLL) Treatment Market worth $3.3 billion by 2018
  • New Entrants to Boost Chronic Lymphocytic Leukemia Treatment Market Value to $3.3 Billion by 2018, says GlobalData. The introduction of several new drugs will accelerate growth in the Chronic Lymphocytic Leukemia (CLL) treatment market, from $1.4 billion in 2013 to …

  • Global Biosimilars Market to Grow at a CAGR of 8.3%, to reach $262 billion by 2019
  • Lucrative Biosimilars Space to Erode Biologics Market from 2019, says GlobalData The increasing prevalence of biosimilars will have a noticeably negative impact on the biologics market beyond 2019, despite an initial projected Compound Annual Growth Rate (CAGR) of 8.3%, taking …

  • Saudi Pharmaceutical Market worth $5.9 billion by 2020
  • A high burden of chronic diseases, improving regulatory guidelines and the launch of new products will provide the necessary impetus for the growth of the pharmaceutical market in Saudi Arabia The Saudi pharmaceutical market is one of the largest markets …

  • DePuy Synthes: Organization, Technologies, Products, Marketing, R&D, Strategies
    Published: 24-Jul-2014        Price: US $1850 Onwards        Pages: 46
    A strategic assessment of Depuy Synthes, one of the world's leading orthopedics companies, provides significant competitor information, analysis, and insight critical to the development and implementation of effective marketing and R&D programs. The report presents a comprehensive analysis of the company's performance, capabilities, goals and strategies in the global orthopedics market.......
  • China Hemodialysis Equipment Import and Export Report, 2013-2016
    Published: 23-Jul-2014        Price: US $2100 Onwards        Pages: 68
    Hemodialysis equipment is the most widely used treatment apparatus in blood purification, primarily targeting patients with acute or chronic renal failure.The Chinese hemodialysis equipment market shows a high concentration, mainly occupied by European, American and Japanese enterprises. In 2013, the import independent rate was around 70%.Imports: Along with the growing demand for hemodialysis equipment in China, its import value also rose fast at a CAGR of 20% in 2009-2013. Germany, Swe......
  • 2014 Deep Research Report on Global and China Laser Scanning Confocal Microscope Industry
    Published: 23-Jul-2014        Price: US $2200 Onwards        Pages: 187
    This is a professional and depth research report on Global and China Laser Scanning Confocal Microscope industry. The report firstly introduced Laser Scanning Confocal Microscope basic information included Laser Scanning Confocal Microscope definition classification application industry chain structure industry overview; Laser Scanning Confocal Microscope production and sales by manufacturers by technology by regions or countries, and also introduced global key manufacturers manufacturing bases ......
  • Sri Lanka Pharmaceuticals and Healthcare Report Q3 2014
    Published: 23-Jul-2014        Price: US $1295 Onwards        Pages: 80
    BMI View: Sri Lanka's pharmaceutical sector has received investment from domestic and foreign - notably Indian - investors in recent years, as economic growth has picked up and the government focused on improving the domestic pharmaceutical sector. We therefore expect that pharmaceutical and healthcare sector growth will outpace economic growth over the five-year forecast period. Improved relations with India, after the country abstained from voting on the UNHCR resolution, are likely to spur fu......
  • United Arab Emirates Pharmaceuticals and Healthcare Report Q3 2014
    Published: 23-Jul-2014        Price: US $1295 Onwards        Pages: 126
    BMI View: The UAE is one of the more developed markets in the Middle East and has a strong existing healthcare infrastructure. As the UAE is aiming to introduce comprehensive health insurance throughout the country, allowing businesses to shoulder much of the cost of this expanded coverage, the government will gradually contribute less to the country's healthcare spending. Between 2013 and 2018, we expect private sector healthcare spending to outpace public. However, the public sector will remai......
  • Czech Republic Pharmaceuticals and Healthcare Report Q3 2014
    Published: 23-Jul-2014        Price: US $1295 Onwards        Pages: 112
    BMI View: Pharmaceutical sales will decline further this year, following the release of poor sales data from the first quarter. Price declines throughout Europe and restructuring of the healthcare system will continue to impact demand within the Czech Republic. We also believe the new centre-left coalition government poses downside risk to our forecasts given its commitment to containing healthcare costs and improving access to medicines. Despite these concerns, our view is more optimistic over ......
  • Denmark Pharmaceuticals and Healthcare Report Q3 2014
    Published: 23-Jul-2014        Price: US $1295 Onwards        Pages: 58
    BMI View: Like many other Western European countries, Denmark's expanding elderly population will ensure that demand for quality healthcare remains high and will be a key driving factor for its wellestablished, albeit relatively small, pharmaceutical market. The robust demand for healthcare services will see the Danish government continue to adapt strategies and cost-containment measures to manage increasing healthcare costs. Despite this, we believe the country's high per-capita drug expenditur......
  • France Infectious Disease Molecular Diagnostics Market: Country Forecasts, Supplier Shares, Emerging Technologies, Competitive Landscape
    Published: 23-Jul-2014        Price: US $4350 Onwards        Pages: 615
    This new study from Venture Planning Group contains 615 pages, 26 tables, and is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the infectious disease molecular diagnostics market during the next five years.Report HighlightsBusiness and technological trends in major markets Five-year test volume and sales forecasts Market shares of leading competitors Feature comparison of major analyzers Strategic profiles of lea......
  • Iraq Pharmaceuticals and Healthcare Report Q3 2014
    Published: 23-Jul-2014        Price: US $1295 Onwards        Pages: 83
    BMI View: Thanks to the government's expansionary fiscal policy, spending on education, health and public services will increase. The Iraqi government has reportedly pledged to invest USD12bn into healthcare expansions in 2014, and the Ministry of Health recently awarded 18 health project contracts worth USD276mn. In addition, new restrictions aim to end the chaos in which materials have entered the country in previous years, targeting control over drug policy and ensuring the supply of medicine......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs